Variant report

Variant	nsv569607
Chromosome Location	chr15:60303749-60347452
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:105)
CpG islands
(count:184)
Chromatin interactive
region (count:6)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:105 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr15:60313715-60314544	K562	blood:	n/a	n/a
2	ATF1	chr15:60327596-60327858	K562	blood:	n/a	n/a
3	ATF1	chr15:60330938-60331112	K562	blood:	n/a	n/a
4	ATF1	chr15:60309924-60310391	K562	blood:	n/a	n/a
5	ATF1	chr15:60337165-60337365	K562	blood:	n/a	n/a
6	ATF1	chr15:60312943-60313351	K562	blood:	n/a	n/a
7	ATF1	chr15:60317902-60318198	K562	blood:	n/a	n/a
8	BATF	chr15:60325729-60325922	GM12878	blood:	n/a	n/a
9	CEBPB	chr15:60337170-60337449	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr15:60337126-60337473	H1-hESC	embryonic stem cell:	n/a	n/a
11	CEBPB	chr15:60310166-60310326	K562	blood:	n/a	n/a
12	CEBPB	chr15:60310026-60310418	Hela-S3	cervix:	n/a	n/a
13	CTCF	chr15:60330400-60330550	WERI-Rb-1	eye:	n/a	chr15:60330526-60330535
14	CTCF	chr15:60345400-60345550	HMEC	breast:	n/a	n/a
15	CTCF	chr15:60330500-60330650	NHEK	skin:	n/a	chr15:60330526-60330535
16	E2F4	chr15:60310236-60310435	MCF10A-Er-Src	breast:	n/a	n/a
17	E2F4	chr15:60345087-60345415	MCF10A-Er-Src	breast:	n/a	n/a
18	ELK1	chr15:60337126-60337330	Hela-S3	cervix:	n/a	n/a
19	EP300	chr15:60310083-60310320	Hela-S3	cervix:	n/a	n/a
20	EP300	chr15:60313888-60314045	K562	blood:	n/a	n/a
21	FOS	chr15:60318899-60319072	MCF10A-Er-Src	breast:	n/a	n/a
22	FOS	chr15:60340010-60340211	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr15:60339974-60340256	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr15:60330943-60331143	MCF10A-Er-Src	breast:	n/a	n/a
25	FOS	chr15:60318912-60318985	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr15:60339996-60340276	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr15:60345069-60345352	MCF10A-Er-Src	breast:	n/a	n/a
28	FOS	chr15:60310026-60310385	MCF10A-Er-Src	breast:	n/a	n/a
29	FOS	chr15:60310032-60310435	MCF10A-Er-Src	breast:	n/a	n/a
30	FOS	chr15:60318883-60319021	MCF10A-Er-Src	breast:	n/a	n/a
31	FOS	chr15:60337297-60337359	MCF10A-Er-Src	breast:	n/a	n/a
32	FOS	chr15:60310007-60310544	MCF10A-Er-Src	breast:	n/a	n/a
33	FOS	chr15:60343315-60343641	MCF10A-Er-Src	breast:	n/a	n/a
34	FOS	chr15:60327659-60327860	MCF10A-Er-Src	breast:	n/a	n/a
35	FOS	chr15:60343310-60343625	MCF10A-Er-Src	breast:	n/a	n/a
36	FOS	chr15:60344948-60345395	MCF10A-Er-Src	breast:	n/a	n/a
37	FOS	chr15:60309999-60310466	MCF10A-Er-Src	breast:	n/a	n/a
38	FOS	chr15:60339971-60340252	MCF10A-Er-Src	breast:	n/a	n/a
39	FOS	chr15:60344949-60345399	MCF10A-Er-Src	breast:	n/a	n/a
40	FOS	chr15:60343317-60343649	MCF10A-Er-Src	breast:	n/a	n/a
41	FOS	chr15:60318882-60319044	MCF10A-Er-Src	breast:	n/a	n/a
42	FOS	chr15:60345027-60345325	MCF10A-Er-Src	breast:	n/a	n/a
43	FOS	chr15:60343373-60343640	MCF10A-Er-Src	breast:	n/a	n/a
44	FOXA1	chr15:60327619-60327751	T-47D	breast:	n/a	n/a
45	FOXA1	chr15:60327563-60327941	HepG2	liver:	n/a	chr15:60327745-60327760
46	FOXA2	chr15:60327552-60327967	A549	lung:	n/a	n/a
47	JUN	chr15:60310089-60310289	K562	blood:	n/a	n/a
48	JUND	chr15:60310002-60310320	K562	blood:	n/a	chr15:60310160-60310171
49	JUND	chr15:60337178-60337474	H1-hESC	embryonic stem cell:	n/a	n/a
50	JUND	chr15:60310006-60310296	HepG2	liver:	n/a	chr15:60310160-60310171

(count:184 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:60337250-60337300	GM12878	blood:	n/a
2	chr15:60337250-60337300	GM12878	blood:	n/a
3	chr15:60331745-60331795	ECC-1	luminal epithelium:	n/a
4	chr15:60337250-60337300	SK-N-SH	brain:	n/a
5	chr15:60337250-60337300	K562	blood:	n/a
6	chr15:60331745-60331795	HL-60	blood:	n/a
7	chr15:60331745-60331795	HCF	heart:	n/a
8	chr15:60331745-60331795	Hepatocyte	liver:	n/a
9	chr15:60304340-60304390	SKMC	muscle:	n/a
10	chr15:60331745-60331795	RPTEC	kidney:	n/a
11	chr15:60331745-60331795	HEK293	kidney:	embryo
12	chr15:60337250-60337300	GM06990	blood:	n/a
13	chr15:60331745-60331795	HCM	heart:	n/a
14	chr15:60304340-60304390	HAEpiC	amniotic membrane:	n/a
15	chr15:60304340-60304390	AG09309	skin:	n/a
16	chr15:60331745-60331795	HRCEpiC	kidney:	n/a
17	chr15:60331745-60331795	SKMC	muscle:	n/a
18	chr15:60337250-60337300	HEEpiC	esophagus:	n/a
19	chr15:60304340-60304390	HEK293	kidney:	embryo
20	chr15:60337250-60337300	HCF	heart:	n/a
21	chr15:60304340-60304390	IMR90	lung:	fetal
22	chr15:60304340-60304390	NB4	blood:	n/a
23	chr15:60331745-60331795	NH-A	brain:	n/a
24	chr15:60331745-60331795	SK-N-SH_RA	brain:	n/a
25	chr15:60304340-60304390	Hepatocyte	liver:	n/a
26	chr15:60337250-60337300	PFSK-1	brain:	n/a
27	chr15:60304340-60304390	PrEC	prostate:	n/a
28	chr15:60304340-60304390	HCF	heart:	n/a
29	chr15:60304340-60304390	NT2-D1	testis:	n/a
30	chr15:60331745-60331795	HCPEpiC	choroid plexus:	n/a
31	chr15:60304340-60304390	GM06990	blood:	n/a
32	chr15:60304340-60304390	HIPEpiC	eye:	n/a
33	chr15:60304340-60304390	HPAEpiC	pulmonary alveolar:	n/a
34	chr15:60337250-60337300	RPTEC	kidney:	n/a
35	chr15:60331745-60331795	U87	brain:	n/a
36	chr15:60304340-60304390	AG04450	lung:	fetal
37	chr15:60331745-60331795	Caco-2	colon:	n/a
38	chr15:60304340-60304390	U87	brain:	n/a
39	chr15:60331745-60331795	HUVEC	blood vessel:	n/a
40	chr15:60337250-60337300	HNPCEpiC	eye:	n/a
41	chr15:60304340-60304390	HL-60	blood:	n/a
42	chr15:60304340-60304390	SK-N-SH_RA	brain:	n/a
43	chr15:60304340-60304390	SK-N-MC	brain:	n/a
44	chr15:60304340-60304390	ECC-1	luminal epithelium:	n/a
45	chr15:60331745-60331795	NB4	blood:	n/a
46	chr15:60331745-60331795	A549	lung:	n/a
47	chr15:60304340-60304390	BJ	skin:	n/a
48	chr15:60337250-60337300	Caco-2	colon:	n/a
49	chr15:60337250-60337300	GM12892	blood:	n/a
50	chr15:60337250-60337300	BE2_C	brain:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:60298753..60300794-chr15:60304335..60307250,2	K562	blood:
2	chr15:60321662..60323517-chr15:60325565..60328073,2	K562	blood:
3	chr15:60336258..60337887-chr15:60346739..60349719,2	MCF-7	breast:
4	chr15:60321662..60323517-chr15:60325565..60328073,2	K562	blood:
5	chr15:59982661..59985453-chr15:60307670..60309447,2	K562	blood:
6	chr15:60336258..60337887-chr15:60346739..60349719,2	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FOXB1-6	chr15:60328329-60328441	NONHSAT044193
2	lnc-ANXA2-3	chr15:60345403-60346291	NONHSAT044194
3	lnc-FOXB1-6	chr15:60333811-60334098	NONHSAT044193
4	lnc-FOXB1-6	chr15:60328309-60328428	NONHSAT044192
5	lnc-FOXB1-6	chr15:60317955-60318108	NONHSAT044192

No data

Variant related genes	Relation type
FOXB1	TF binding region
MESTP2	TF binding region
FOXB1	CpG island
MESTP2	CpG island

Extended variants
information (count: 1622 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:1622 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4775230	chr15:60303749-60303750	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs554381426	chr15:60303751-60303752	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs572980138	chr15:60303756-60303757	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs578030996	chr15:60303797-60303798	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs191471719	chr15:60303888-60303889	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs541521929	chr15:60303897-60303898	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs112867895	chr15:60303943-60303944	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs369975389	chr15:60303998-60303999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs373356194	chr15:60304038-60304039	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs6494159	chr15:60304043-60304044	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs572431534	chr15:60304052-60304053	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs75390752	chr15:60304102-60304103	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs555782398	chr15:60304156-60304157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs544523704	chr15:60304280-60304281	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs574186224	chr15:60304297-60304298	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs183375403	chr15:60304330-60304331	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs111636749	chr15:60304336-60304337	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs560310788	chr15:60304370-60304371	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs572135179	chr15:60304438-60304439	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs374414502	chr15:60304596-60304597	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs545897242	chr15:60304659-60304660	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs77630477	chr15:60304660-60304661	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs531202757	chr15:60304678-60304679	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs533024352	chr15:60304720-60304721	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs188783898	chr15:60304779-60304780	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs554195039	chr15:60304810-60304811	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs5812995	chr15:60304811-60304812	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs75604192	chr15:60304821-60304822	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs63654461	chr15:60304822-60304823	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs561795609	chr15:60304823-60304824	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs112445551	chr15:60304825-60304826	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs140371588	chr15:60304841-60304842	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs565853330	chr15:60304908-60304909	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs76362090	chr15:60304922-60304923	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs986694	chr15:60304969-60304970	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs570078921	chr15:60305007-60305008	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs143254978	chr15:60305009-60305010	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs185857084	chr15:60305012-60305013	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs567834728	chr15:60305021-60305022	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs187796417	chr15:60305025-60305026	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs143595978	chr15:60305045-60305046	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs113612119	chr15:60305057-60305058	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs578199463	chr15:60305100-60305101	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs545964718	chr15:60305128-60305129	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs142250802	chr15:60305129-60305130	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs56090734	chr15:60305168-60305169	Enhancers Bivalent Enhancer Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs543006552	chr15:60305231-60305232	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs986693	chr15:60305232-60305233	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs529120025	chr15:60305242-60305243	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs377627106	chr15:60305256-60305257	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	21129771	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Holoprosencephaly	21359414	CNVD
Myelofibrosis	22110671	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Mental retardation	17124404	CNVD
Gastrointestinal stromal cancer	20877625	CNVD

Chromatin state (count:247 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:60299000-60314400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr15:60299400-60305200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
3	chr15:60300200-60305200	Enhancers	H1 Cell Line	embryonic stem cell
4	chr15:60300800-60305400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr15:60302800-60305400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr15:60303200-60306400	Enhancers	HUES64 Cell Line	embryonic stem cell
7	chr15:60303400-60305000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr15:60303400-60305200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
9	chr15:60303400-60305200	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr15:60303400-60305400	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr15:60303400-60306000	Enhancers	iPS-20b Cell Line	embryonic stem cell
12	chr15:60303600-60304000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr15:60303600-60304600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr15:60303600-60305400	Enhancers	HUES48 Cell Line	embryonic stem cell
15	chr15:60303600-60306000	Enhancers	iPS-18 Cell Line	embryonic stem cell
16	chr15:60303800-60304800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr15:60304000-60305200	Enhancers	ES-I3 Cell Line	embryonic stem cell
18	chr15:60304600-60304800	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
19	chr15:60304600-60306000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr15:60304800-60305200	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
21	chr15:60305000-60305200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr15:60305400-60306200	Weak transcription	HUES48 Cell Line	embryonic stem cell
23	chr15:60306000-60306200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr15:60306000-60308400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
25	chr15:60306200-60306400	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr15:60306400-60314200	Weak transcription	HUES64 Cell Line	embryonic stem cell
27	chr15:60308400-60308600	Enhancers	iPS-18 Cell Line	embryonic stem cell
28	chr15:60309600-60310800	Enhancers	Dnd41	blood
29	chr15:60309800-60310400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
30	chr15:60309800-60310800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
31	chr15:60309800-60311000	Enhancers	HMEC	breast
32	chr15:60310000-60310400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
33	chr15:60310000-60310600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
34	chr15:60310200-60310400	Enhancers	Primary T helper naive cells from peripheral blood	blood
35	chr15:60310200-60310400	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr15:60310200-60310600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr15:60310200-60310600	Enhancers	Primary monocytes fromperipheralblood	blood
38	chr15:60310200-60310600	Enhancers	NHEK	skin
39	chr15:60310400-60310600	Enhancers	Primary hematopoietic stem cells short term culture	blood
40	chr15:60310600-60312800	Weak transcription	NHEK	skin
41	chr15:60310600-60313000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
42	chr15:60310800-60311000	Bivalent/Poised TSS	Right Atrium	heart
43	chr15:60310800-60313600	Weak transcription	Dnd41	blood
44	chr15:60311000-60313000	Weak transcription	HMEC	breast
45	chr15:60312600-60314800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
46	chr15:60312800-60315200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr15:60312800-60315200	Enhancers	NHEK	skin
48	chr15:60313000-60313200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
49	chr15:60313000-60313200	Enhancers	iPS-15b Cell Line	embryonic stem cell
50	chr15:60313000-60314600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links